Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors

Cancer Research

Volumn 68, Issue 8, 2008, Pages 2641-2651

  Acevedo, Luis G ^a   Bieda, Mark ^a   Green, Roland ^b   Farnham, Peggy J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Roche NimbleGen Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; MESSENGER RNA; RNA POLYMERASE II; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING;

AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CRYOPRESERVATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); RNA; RNA, NEOPLASM; TRANSCRIPTION, GENETIC;

EID: 41649107645     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5590     Document Type: Article

References (32)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and Molecular Carcinogenesis. Rev Basic Clin Gastroenterol 2007;132:2557-76.
2. Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002;13:1929-39.
3. Xu L, Hui L, Wang S, et al. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001;61:3176-81.
4. Graveel CR, Harkins-Perry SR, Acevedo LG, Farnham PJ. Identification and characterization of CRG-L2, a new marker for liver tumor development. Oncogene 2003;22:1730-6.
5. Graveel CR, Jatkoe T, Madore SJ, Holt AL, Farnham PJ. Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene 2001;20:2704-12.
6. Lee J-S, Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 2002;35:1134-43.
7. Delpuech O, Trabut J-B, Carnot F, Feuillard J, Brechot C, Kremsdorf D. Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene 2002;21:2926-37.
8. Su W-H, Chao C-C, Yeh S-H, Chen D-S, Chen P-J, Jou Y-S. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 2006;35:D727-31.
9. Higashitsuji H, Higashitsuji H, Itoh K, et al. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 2005;8:75-87.
10. Higashitsuji H, Itoh K, Nagao T, et al. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med 2000;6:96-9.
11. Li H, Fu X, Chen Y, et al. Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma. Gastroenterology 2005;128:2029-41.
12. Sigalotti L, Fratta E, Coral S, et al. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. J Cell Physiol 2007;212:330-44.
13. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 2002;18:207-8.
14. Weinmann AS, Bartley SM, Zhang MQ, Zhang T, Farnham PJ. The use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol 2001;21:6820-32.
15. Acevedo LG, Iniguez AL, Holster HL, Zhang X, Green R, Farnham PJ. Genome-scale ChIP-chip analysis using 10,000 human cells. Biotechniques 2007;43:791-7.
16. O'Geen H, Nicolet CM, Blahnik K, Green R, Farnham PJ. Comparison of sample preparation methods for ChIP-chip assays. Biotechniques 2006;41:577-80.
17. Krig SR, Jin VX, Bieda MC, et al. Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays. J Biol Chem 2007;282:9703-12.
18. Dennis GJ, Sherman BT, Hosack Da, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003;4:P3.
19. Kondoh N, Shuda M, Tanaka K, Wakatsuki T, Hada A, Yamamoto M. Enhanced expression of S8, L12, L23a, L27, and L30 ribosomal protein mRNAs in human hepatocellular carcinomas. Anticancer Res 2001;21:2429-33.
20. Tao X, Zheng JM, Chen XF, Zhang SH. Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. Hepatol Res 2007;37:820-7.
21. Squazzo SL, Komashko VM, O'Geen H, et al. Suz12 silences large regions of the genome in a cell type-specific manner. Genome Res 2006;16:890-900.
22. Urban AE, Korbel JO, Selzer R, et al. High-resolution mapping of DNA copy alterations in human chromosome 22 using high-density tiling oligonucleotide arrays. Proc Natl Acad Sci U S A 2006;103:4534-9.
23. Chang J, Kim N-G, Piao Z, et al. Assessment of chromosomal losses and gains in hepatocellular carcinoma. Cancer Lett 2002;182:193-202.
24. Patil MA, Gutgemann I, Zhang J, et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005;26:2050-7.
25. Chatterjee R. Cases of Mistaken Identity. Science 2007;315:928-31.
26. Macville M, Schrock E, Padilla-Nash H, et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 1999;59:141-50.
27. Oosterhuis JW, Looijenga LHJ. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005;5:210-22.
28. Cao D, Hustinx SR, Sui G, et al. Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags. Cancer Biol Ther 2004;3:1081-9.
29. Saitoh T, Katoh M. Expression of human SOX18 in normal tissues and tumors. Int J Mol Med 2002;10:339-44.
30. Yasui K, Arii S, Zhao C, et al. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 113q34 in hepatocellular carcinomas. Hepatology 2002;35:1476-84.
31. Yasui K, Okamoto H, Arii S, Inazawa J. Association of over-expressed TFDP1 with progression of hepatocellular carcinomas. J Hum Genet 2003;48:609-13.
32. Kimura K, Wakamatsu A, Suzuki Y, et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 2006;16:55-65.